Tolamolol in the treatment of hypertension: an open evaluation study.
The effect of tolamolol 50-300 mg three times daily in the treatment of 30 patients with mild-severe hypertension was studied. The duration of therapy in the majority of cases was 3-6 months. There was a highly significant reduction of mean blood pressure (p less than 0.001) for the group as a whole. Overall, 61% of patients became normotensive or showed a reduction in severity of hypertension, In the majority of cases, this improvement occurred within the first four weeks of therapy. There was not postural hypertension. Apart from one patient with Prurigo Besnier who developed asthma, another patient who developed severe headache and a third patient who stopped treatment without giving a reason, treatment was well tolerated and there were no other serious side or toxic effects.
D000328:Adult; D001794:Blood Pressure; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011412:Propanolamines / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D011412:Propanolamines